vs
DigitalOcean Holdings, Inc.（DOCN）与Organogenesis Holdings Inc.（ORGO）财务数据对比。点击上方公司名可切换其他公司
DigitalOcean Holdings, Inc.的季度营收约是Organogenesis Holdings Inc.的6.5倍（$242.4M vs $37.2M），DigitalOcean Holdings, Inc.同比增速更快（18.3% vs -57.1%），过去两年DigitalOcean Holdings, Inc.的营收复合增速更高（14.5% vs -46.5%）
DigitalOcean Holdings, Inc.是美国跨国科技企业及云服务提供商，总部位于美国科罗拉多州布鲁姆菲尔德，在全球布局15个数据中心，面向开发者、初创企业及中小微企业提供稳定易用的云基础设施即服务平台，助力各类技术团队高效开展业务。
Organogenesis Holdings Inc.是一家领先的再生医学企业，专注于开发、生产用于伤口护理、外科修复、运动医学和皮肤病领域的先进治疗产品，主要服务美国及部分国际市场的医疗机构与患者，提供经临床验证的医疗解决方案。
DOCN vs ORGO — 直观对比
营收规模更大
DOCN
是对方的6.5倍
$37.2M
营收增速更快
DOCN
高出75.3%
-57.1%
两年增速更快
DOCN
近两年复合增速
-46.5%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $242.4M | $37.2M |
| 净利润 | $25.7M | — |
| 毛利率 | 58.7% | 30.8% |
| 营业利润率 | 16.0% | -185.1% |
| 净利率 | 10.6% | — |
| 营收同比 | 18.3% | -57.1% |
| 净利润同比 | 40.5% | — |
| 每股收益（稀释后） | $0.23 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOCNORGO
| Q1 26 | — | $37.2M | ||
| Q4 25 | $242.4M | $225.6M | ||
| Q3 25 | $229.6M | $150.9M | ||
| Q2 25 | $218.7M | $101.0M | ||
| Q1 25 | $210.7M | $86.7M | ||
| Q4 24 | $204.9M | $126.7M | ||
| Q3 24 | $198.5M | $115.2M | ||
| Q2 24 | $192.5M | $130.2M |
净利润DOCNORGO
| Q1 26 | — | — | ||
| Q4 25 | $25.7M | $43.7M | ||
| Q3 25 | $158.4M | $21.6M | ||
| Q2 25 | $37.0M | $-9.4M | ||
| Q1 25 | $38.2M | $-18.8M | ||
| Q4 24 | $18.3M | $7.7M | ||
| Q3 24 | $32.9M | $12.3M | ||
| Q2 24 | $19.1M | $-17.0M |
毛利率DOCNORGO
| Q1 26 | — | 30.8% | ||
| Q4 25 | 58.7% | — | ||
| Q3 25 | 59.6% | — | ||
| Q2 25 | 59.9% | — | ||
| Q1 25 | 61.4% | 72.6% | ||
| Q4 24 | 57.1% | 75.5% | ||
| Q3 24 | 60.2% | 76.7% | ||
| Q2 24 | 61.0% | 77.6% |
营业利润率DOCNORGO
| Q1 26 | — | -185.1% | ||
| Q4 25 | 16.0% | 28.1% | ||
| Q3 25 | 19.6% | 13.7% | ||
| Q2 25 | 16.3% | -12.5% | ||
| Q1 25 | 17.9% | -30.9% | ||
| Q4 24 | 15.9% | 8.1% | ||
| Q3 24 | 12.4% | 5.4% | ||
| Q2 24 | 11.6% | -10.7% |
净利率DOCNORGO
| Q1 26 | — | — | ||
| Q4 25 | 10.6% | 19.4% | ||
| Q3 25 | 69.0% | 14.3% | ||
| Q2 25 | 16.9% | -9.3% | ||
| Q1 25 | 18.1% | -21.7% | ||
| Q4 24 | 8.9% | 6.1% | ||
| Q3 24 | 16.6% | 10.7% | ||
| Q2 24 | 9.9% | -13.1% |
每股收益（稀释后）DOCNORGO
| Q1 26 | — | — | ||
| Q4 25 | $0.23 | $0.31 | ||
| Q3 25 | $1.51 | $0.11 | ||
| Q2 25 | $0.39 | $-0.10 | ||
| Q1 25 | $0.39 | $-0.17 | ||
| Q4 24 | $0.21 | $0.05 | ||
| Q3 24 | $0.33 | $0.09 | ||
| Q2 24 | $0.20 | $-0.13 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $254.5M | $91.4M |
| 总债务越低越好 | $1.3B | — |
| 股东权益账面价值 | $-28.7M | — |
| 总资产 | $1.8B | $520.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DOCNORGO
| Q1 26 | — | $91.4M | ||
| Q4 25 | $254.5M | $93.7M | ||
| Q3 25 | $236.6M | $63.7M | ||
| Q2 25 | $387.7M | $73.1M | ||
| Q1 25 | $360.4M | $110.0M | ||
| Q4 24 | $428.4M | $135.6M | ||
| Q3 24 | $439.9M | $94.3M | ||
| Q2 24 | $443.1M | $89.9M |
总债务DOCNORGO
| Q1 26 | — | — | ||
| Q4 25 | $1.3B | — | ||
| Q3 25 | $1.3B | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $1.5B | — | ||
| Q3 24 | — | $62.3M | ||
| Q2 24 | — | $63.8M |
股东权益DOCNORGO
| Q1 26 | — | — | ||
| Q4 25 | $-28.7M | $300.1M | ||
| Q3 25 | $-69.6M | $255.1M | ||
| Q2 25 | $-175.2M | $233.2M | ||
| Q1 25 | $-210.7M | $242.9M | ||
| Q4 24 | $-203.0M | $262.9M | ||
| Q3 24 | $-211.7M | $278.5M | ||
| Q2 24 | $-253.8M | $263.5M |
总资产DOCNORGO
| Q1 26 | — | $520.0M | ||
| Q4 25 | $1.8B | $598.7M | ||
| Q3 25 | $1.7B | $509.8M | ||
| Q2 25 | $1.7B | $461.1M | ||
| Q1 25 | $1.6B | $467.4M | ||
| Q4 24 | $1.6B | $497.9M | ||
| Q3 24 | $1.5B | $446.3M | ||
| Q2 24 | $1.5B | $443.2M |
负债/权益比DOCNORGO
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.22× | ||
| Q2 24 | — | 0.24× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $57.3M | — |
| 自由现金流经营现金流 - 资本支出 | $31.1M | — |
| 自由现金流率自由现金流/营收 | 12.8% | — |
| 资本支出强度资本支出/营收 | 10.8% | — |
| 现金转化率经营现金流/净利润 | 2.23× | — |
| 过去12个月自由现金流最近4个季度 | $180.5M | — |
8季度趋势，按日历期对齐
经营现金流DOCNORGO
| Q1 26 | — | — | ||
| Q4 25 | $57.3M | $39.4M | ||
| Q3 25 | $95.8M | $3.1M | ||
| Q2 25 | $92.4M | $-32.9M | ||
| Q1 25 | $64.1M | $-19.9M | ||
| Q4 24 | $71.3M | $10.9M | ||
| Q3 24 | $73.4M | $8.7M | ||
| Q2 24 | $71.3M | $4.7M |
自由现金流DOCNORGO
| Q1 26 | — | — | ||
| Q4 25 | $31.1M | $34.8M | ||
| Q3 25 | $88.0M | $844.0K | ||
| Q2 25 | $59.3M | $-36.5M | ||
| Q1 25 | $2.1M | $-23.6M | ||
| Q4 24 | $26.1M | $7.6M | ||
| Q3 24 | $16.0M | $6.1M | ||
| Q2 24 | $39.5M | $2.9M |
自由现金流率DOCNORGO
| Q1 26 | — | — | ||
| Q4 25 | 12.8% | 15.4% | ||
| Q3 25 | 38.3% | 0.6% | ||
| Q2 25 | 27.1% | -36.1% | ||
| Q1 25 | 1.0% | -27.2% | ||
| Q4 24 | 12.7% | 6.0% | ||
| Q3 24 | 8.1% | 5.3% | ||
| Q2 24 | 20.5% | 2.2% |
资本支出强度DOCNORGO
| Q1 26 | — | — | ||
| Q4 25 | 10.8% | 2.1% | ||
| Q3 25 | 3.4% | 1.5% | ||
| Q2 25 | 15.2% | 3.6% | ||
| Q1 25 | 29.4% | 4.2% | ||
| Q4 24 | 22.1% | 2.7% | ||
| Q3 24 | 28.9% | 2.2% | ||
| Q2 24 | 16.6% | 1.4% |
现金转化率DOCNORGO
| Q1 26 | — | — | ||
| Q4 25 | 2.23× | 0.90× | ||
| Q3 25 | 0.60× | 0.14× | ||
| Q2 25 | 2.50× | — | ||
| Q1 25 | 1.68× | — | ||
| Q4 24 | 3.91× | 1.43× | ||
| Q3 24 | 2.23× | 0.71× | ||
| Q2 24 | 3.73× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOCN
| Scalers | $84.3M | 35% |
| Scalers Plus | $69.9M | 29% |
| Builders | $64.1M | 26% |
| Learners Testers And Other | $24.1M | 10% |
ORGO
暂无分部数据
